Polar Capital Funds PLC - Biotechnology Fund R Fonds
36,26
EUR
-0,18
EUR
-0,50
%
gettex
41,00
USD
+0,23
USD
+0,56
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| argenx SE | NL0010832176 | 7,34% |
| Arcutis Biotherapeutics Inc Ordinary Shares | US03969K1088 | 5,24% |
| Ascendis Pharma AS ADR | US04351P1012 | 4,57% |
| SpringWorks Therapeutics Inc Ordinary Shares | US85205L1070 | 4,31% |
| Scholar Rock Holding Corp | US80706P1030 | 4,27% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,96% |
| Zealand Pharma AS | DK0060257814 | 3,76% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,39% |
| Xenon Pharmaceuticals Inc | CA98420N1050 | 3,28% |
| UCB SA | BE0003739530 | 3,19% |
| Sonstige | 56,69% |